MÜMelek Ünçel

Melek Ünçel

*This is an algorithmically generated author record based on publicly available information.

Melek Ünçel has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Inflammation Tumor Microenvironment and Mast Cells in Breast Cancer

    by Leyla Tekin, Melek Ünçel

    The tumor microenvironment consists of fibroblasts, endothelial and immune cells, and extracellular matrix and envelops the cancer. Mast cells are associated with angiogenesis, immunomodulation of the stroma, and tissue remodeling in cancers. In different tumors, it may have antitumor or potentiating effects in relation to the tumor microenvironment. Immune cells in breast cancer stroma form the inflammatory microenvironment that shapes cancer behavior. Samples taken from 85 female patients who underwent mastectomy due to breast cancer between 2017 and 2020 were evaluated retrospectively. Immunohistochemical staining was performed on the basis of hematoxylin-eosin stained slides. Mast cell density was assessed using the hot-spot method, counting in three high-density areas. Both peritumoral and intratumoral densities were recorded separately, and average counts were calculated from the three fields. CD117 was counted at three high magnifications (400x), and intratumoral and peritumoral cells were distinguished. The presence of intratumoral fibrosis and lymphocytes was scored . Peritumoral mast cell count was found to be below average in ER-negative cases and in cases with high metastatic lymph node count. An inverse relationship was observed between lobular carcinoma and intratumoral mast cell density. In addition, there was a significant inverse relationship between intratumoral mast cell density and increased tumor size. Cases with below average intratumoral mast cell count were significantly associated with ER negativity, high Ki67 proliferation index, , luminal group cases and absence of fibrosis. Low mast cell count in tumors was found to be associated with poor prognostic parameters.

  • Open Access

    Kliniğimizde gerçekleşen abortusların molar gebelik sıklığı ve ön-tanı başarısı

    by Özge Şehi̇rli̇ Kinci, Mehmet Ferdi Kinci, Mehmet Onur Arslaner, Firangiz Mi̇rzazada, Melek Ünçel

    Aim: Abortion is the termination of pregnancy before the 20th gestational week or when the fetus is below 500 g. Its prevalence is between 50-70% in all pregnancies. Routine histological examination (HE) of abortion materials is controversial in terms of molar pregnancy (MP) diagnosis. This study aims to determine the necessity of HE by evaluating the MP frequency and pre-diagnosis success of abortions in our clinic. Materials and Methods: In this retrospective study, 1007 women whose pregnancy resulted in abortion between 01.01.2019-01.01.2022 and whose demographic data, USG findings, pre-diagnoses and HE results were present, were included. The preliminary diagnoses of patients with CMH and PMH were compared with the HE results. Results: Among the materials sent to pathology for HE, the most common diagnosis was missed abortion with 590 (58.78%). MP was detected in 32 (3.17%) women. Of these, 9 (0.89%) were found to be CMH, while 23 (2.28%) were PMH. While 6 (66.6%) of 9 patients diagnosed with CMD were prediagnosed with CMD, 10 (43.37%) out of 23 patients diagnosed with PMH were prediagnosed as PMH. Conclusion: Since the prevalence of MP is 3.17% and there is a high inconsistency between the pre-diagnosis and the result of HE, we recommend that all abortion materials be performed with HE.

  • Open Access

    Squamous Cell Carcinoma of The Skin Mimicking Breast Cancer: A Case Report

    by Görkem Türkkan, Furkan Gözübüyük, Kutluhan Çinbay, Emine Erva Özen, Fatih Özdemi̇r, Ali Alkan, Melek Ünçel, Ferda Bacakszilar Sari, Leyla Teki̇n, Funda Di̇nç Eli̇bol, et al.

    Squamous cell carcinoma (SCC) is the second most common skin cancer and it often occurs in sun-exposed areas such as head and neck skin. Invasive SCC located on breast skin is a rare entity and may clinically mimic breast cancer. We report a case of a 39 years old female with a non-eroded, vegetative, growing lesion on the right breast skin, initially mimicking breast cancer both clinically and histopathologically. After surgery with clear margins, adjuvant radiotherapy was administered, by considering the pathological risk factors for recurrence. At 14 months, the patient is disease-free and under regular follow-up. Invasive SCC of the breast skin is a rare entity and may have different etiology/behavior or directly develop de novo when compared to SCCs located on sun-exposed skin. Medical history and physical examination in conjunction with histopathological examination of the biopsy specimen are critical for the accuracy of the diagnosis and the correct treatment decision in patients presenting with a mass invading breast skin.

  • Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers

    by Melek Uncel, Gulden Diniz, Gamze Akoz, Zubeyde Yildirim Ekin, Sevil Saydan, Serdar Yardim, Semra Salimoglu

    Breast cancer is the most common cancer among women worldwide. Adenine thymine-rich interactive domain 1A (ARIDIA) is a tumor suppressor gene involved in chromatin remodeling and it encodes the ARIDIA protein. Recent studies have shown the loss of ARIDIA protein expression in different carcinomas may have a prognostic significance. In the present study, we aimed to evaluate the interactions between ARIDIA loss and molecular subtypes of breast carcinomas. ARIDIA expressions were studied in 292 formalin- fixed, paraffin- embedded breast carcinoma specimens and its association with different pathological and clinical parameters was evaluated. Loss of ARIDIA expression was detected in 123 cases. There was no statistically significant association between ARID-1A expression and molecular subtype of breast carcinomas (p=0.110) or HER2 amplification (p=0.909). Contrarily, there was a significant association between ARIDIA expression and presence of estrogen (p=0.047) or progesterone receptors (p=0.023). Besides a statistically significant relationship was found between loss of ARID1A, and the presence of both in situ component (p=0.016) and lymph node metastasis (p=0.001). In this study, we have demonstrated that loss of ARID1A expression positively correlates with hormone receptor status as well as tumor aggressiveness.